Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0524 per EA under NDC 42571010305. Its NADAC has been published 266 times since Mar 19, 2014.
The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Micro Labs LimitedNDC
42571010305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091220On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 266 times since Mar 19, 2014, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0524 per EA |
|---|---|
| All-time high | $0.2276 (Feb 10, 2016) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0524 |
| 52-week low | $0.0375 |
| Median price | $0.0521 |
| Average price | $0.0850 |
| Largest weekly change | +115.0% (Feb 18, 2015) |
| Weeks tracked | 266 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Micro Labs Limited, is $0.0524 per EA (NDC 42571010305), effective Jun 24, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 9.8%. It has been tracked across 266 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since Mar 19, 2014, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.2276 (Feb 10, 2016), with a median of $0.0521 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GLIMEPIRIDE 4 MG TABLET, is $0.0323 per EA — about 38% below GLIMEPIRIDE 4 MG TABLET.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 42571010305) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification